PIGGY-BACK REGISTRATION RIGHTS AGREEMENTPiggy-Back Registration Rights Agreement • November 17th, 2022 • RespireRx Pharmaceuticals Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledNovember 17th, 2022 Company Industry JurisdictionTHIS PIGGY-BACK REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as «Closing_Date» is made by and between RespireRx Pharmaceuticals Inc., a Delaware corporation (the “Company”), and «Investor» a «State_of_Incorp» «Type_of_Entity» (the “Holder”). The Company and the Holder are hereinafter sometimes collectively referred to as the “Parties” and each a “Party” to this Agreement.
PIGGY-BACK REGISTRATION RIGHTS AGREEMENTPiggy-Back Registration Rights Agreement • October 12th, 2021 • RespireRx Pharmaceuticals Inc. • Pharmaceutical preparations • New York
Contract Type FiledOctober 12th, 2021 Company Industry JurisdictionTHIS PIGGY-BACK REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of October 7, 2021, is made by and between RespireRx Pharmaceuticals Inc., a Delaware corporation (the “Company”), and Dariusz Nasiek and Sara Nasiek, JTTEN (the “Holder”). The Company and the Holder are hereinafter sometimes collectively referred to as the “Parties” and each a “Party” to this Agreement.
PIGGY-BACK REGISTRATION RIGHTS AGREEMENTPiggy-Back Registration Rights Agreement • September 3rd, 2021 • RespireRx Pharmaceuticals Inc. • Pharmaceutical preparations • New York
Contract Type FiledSeptember 3rd, 2021 Company Industry JurisdictionTHIS PIGGY-BACK REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of August 31, 2021, is made by and between RespireRx Pharmaceuticals Inc., a Delaware corporation (the “Company”), and Barton Asset Management LLC a Delaware limited liability company (the “Holder”). The Company and the Holder are hereinafter sometimes collectively referred to as the “Parties” and each a “Party” to this Agreement.
PIGGY-BACK REGISTRATION RIGHTS AGREEMENTPiggy-Back Registration Rights Agreement • July 6th, 2021 • RespireRx Pharmaceuticals Inc. • Pharmaceutical preparations • New York
Contract Type FiledJuly 6th, 2021 Company Industry JurisdictionTHIS PIGGY-BACK REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of June 29, 2021, is made by and between RespireRx Pharmaceuticals Inc., a Delaware corporation (the “Company”), and EMA Financial, LLC, a Delaware limited liability company (the “Holder”). The Company and the Holder are hereinafter sometimes collectively referred to as the “Parties” and each a “Party” to this Agreement.
PIGGY-BACK REGISTRATION RIGHTS AGREEMENTPiggy-Back Registration Rights Agreement • May 14th, 2021 • RespireRx Pharmaceuticals Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMay 14th, 2021 Company Industry JurisdictionTHIS PIGGY-BACK REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of May 10. 2021, is made by and between RespireRx Pharmaceuticals Inc., a Delaware corporation (the “Company”), and LGH Investments, LLC, a Wyoming limited liability company (the “Holder”). The Company and the Holder are hereinafter sometimes collectively referred to as the “Parties” and each a “Party” to this Agreement.
PIGGY-BACK REGISTRATION RIGHTS AGREEMENTPiggy-Back Registration Rights Agreement • May 3rd, 2021 • RespireRx Pharmaceuticals Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMay 3rd, 2021 Company Industry JurisdictionTHIS PIGGY-BACK REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of April 30, 2021, is made by and between RespireRx Pharmaceuticals Inc., a Delaware corporation (the “Company”), and Labrys Fund, LP, a Delaware limited partnership (the “Holder”). The Company and the Holder are hereinafter sometimes collectively referred to as the “Parties” and each a “Party” to this Agreement.
PIGGY-BACK REGISTRATION RIGHTS AGREEMENTPiggy-Back Registration Rights Agreement • April 5th, 2021 • RespireRx Pharmaceuticals Inc. • Pharmaceutical preparations • New York
Contract Type FiledApril 5th, 2021 Company Industry JurisdictionTHIS PIGGY-BACK REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of March 31, 2021, is made by and between RespireRx Pharmaceuticals Inc., a Delaware corporation (the “Company”), and EMA Financial, LLC, a Delaware limited liability company (the “Holder”). The Company and the Holder are hereinafter sometimes collectively referred to as the “Parties” and each a “Party” to this Agreement.